Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Pfizer CEO believes US will eliminate rebates on prescription drugs

      Pfizer CEO believes US will eliminate rebates on prescription drugs

      Ruby Khatun Khatun3 Aug 2018 9:30 AM IST
      NEW YORK: Pfizer Inc Chief Executive Ian Read that he believes the Trump administration intends to eliminate rebates on prescription drug purchases,...
      List of medical devices under public monitoring: Minister Apprises parliament

      List of medical devices under public monitoring: Minister Apprises parliament

      Ruby Khatun Khatun2 Aug 2018 5:12 PM IST
      New Delhi: The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated in a written reply in the Rajya Sabha that 4 devices...
      Zydus Cadila gets USFDA approval for antibacterial drug

      Zydus Cadila gets USFDA approval for antibacterial drug

      Ruby Khatun Khatun2 Aug 2018 11:00 AM IST
      New Delhi: Drug firm Zydus Cadila said it has received approval from the US health regulator to market Azithromycin for Oral Suspension USP, used to...
      Unichem Labs gets USFDA observations for its Pithampur API facility

      Unichem Labs gets USFDA observations for its Pithampur API facility

      Ruby Khatun Khatun2 Aug 2018 10:42 AM IST
      Mumbai: Pharma Major, Unichem Laboratories Ltd's API manufacturing facility at Pithampur, Madhya Pradesh was inspected by USFDA from July 23-27...
      India recalls rabies vaccines made by tainted China firm

      India recalls rabies vaccines made by tainted China firm

      Ruby Khatun Khatun2 Aug 2018 10:00 AM IST
      India has ordered an immediate recall of rabies vaccines made by a scandal-hit Chinese company, India's drug regulator said Wednesday, complaining it...
      Pfizer lowers 2018 revenue forecast, increases research and development spend

      Pfizer lowers 2018 revenue forecast, increases research and development spend

      Ruby Khatun Khatun2 Aug 2018 9:45 AM IST
      Pfizer Inc lowered its revenue forecast for this year, blaming the stronger dollar, and increased its planned spending on research and development, as...
      Positive results from Crohns disease trial: RedHill BioPharma

      Positive results from Crohn's disease trial: RedHill BioPharma

      Ruby Khatun Khatun2 Aug 2018 9:30 AM IST
      TEL AVIV: Israel's RedHill Biopharma said it had positive safety and efficacy results from a late-stage clinical trial with its treatment for Crohn's...
      Overcharging by drug firms- Rs 890 crore recovered till now, Minister informs Parliament

      Overcharging by drug firms- Rs 890 crore recovered till now, Minister informs Parliament

      Ruby Khatun Khatun1 Aug 2018 11:15 AM IST
      Demand notices have been issued for a total amount of Rs 6,058.07 crore. Amount to the tune of Rs 829.88 crore has been recovered from the...
      Morepen labs gets USFDA approval for 2 bulk drug manufacturing units

      Morepen labs gets USFDA approval for 2 bulk drug manufacturing units

      Ruby Khatun Khatun1 Aug 2018 10:47 AM IST
      New Delhi: Morepen Laboratories Ltd. has received USFDA (United States Food and Drug Administration) approvals for both its bulk drugs manufacturing...
      Wockhardt sets up its first manufacturing facility in Dubai

      Wockhardt sets up its first manufacturing facility in Dubai

      Ruby Khatun Khatun1 Aug 2018 10:30 AM IST
      New Delhi: Drug firm Wockhardt has set up its first facility in the Middle East in Dubai for the manufacture of new chemical entities (NCEs) to cater...
      Ajanta Pharma Q1 net up 12 percent at Rs 106 crore

      Ajanta Pharma Q1 net up 12 percent at Rs 106 crore

      Ruby Khatun Khatun1 Aug 2018 10:15 AM IST
      New Delhi: Ajanta Pharma reported 11.60 percent rise in consolidated net profit at Rs 105.79 crore for the June quarter on account of robust sales in...
      Bayer wins EU watchdogs endorsement for wider Xarelto use

      Bayer wins EU watchdog's endorsement for wider Xarelto use

      Ruby Khatun Khatun1 Aug 2018 10:00 AM IST
      FRANKFURT: Bayer won the European Medicines Agency’s (EMA) recommendation for widening the use of its blockbuster clot prevention drug Xarelto to...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok